UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033674
Receipt number R000038392
Scientific Title A proper sedation/analgesia to enhance safety in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer
Date of disclosure of the study information 2018/09/01
Last modified on 2023/08/15 12:35:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A proper sedation/analgesia to enhance safety in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer

Acronym

A proper anesthesia for endoscopic submucosal dissection

Scientific Title

A proper sedation/analgesia to enhance safety in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer

Scientific Title:Acronym

A proper anesthesia for endoscopic submucosal dissection

Region

Japan


Condition

Condition

early gastric cancer/superficial esophageal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to establish a guideline selecting safe and effective way of sedation/analgesia in endoscopic submucosal dissection for early gastric cancer or superficial esophageal cancer.

Basic objectives2

Others

Basic objectives -Others

Evaluation of the difference among the methods of anesthesia with respect to the procedural completeness of ESD and the frequency and severity of complications.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The procedural completeness of ESD (completion rate of ESD in block and histological margin in vertical and horizontal directions on 2 weeks after ESD)

Key secondary outcomes

The frequency and severity of complications (Bleeding, perforation, aspiration pneumonia, respiratory suppression, circular disturbance, cognitive ability, and factors affecting those complications on discharge)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Intravenous anesthesia without intubation (during ESD procedure)

Interventions/Control_2

Systemic anesthesia without intubation (during ESD procedure)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Early gastric cancer
Absolute indication; differentiated adenocarcinoma in situ no larger than 2 cm in diameter without ulcer formation
Relative indication;
i) Absolute indication over 2 cm in diameter
ii) Absolute indication less than 3 cm with ulcer formation
iii) Absolute indication, but poorly differentiated adenocarcinoma


Superficial esophageal cancer
Absolute indication; squamous cell carcinoma invading no deeper than the submucosa and less than two-thirds of circumference
Relative indication;
i) Absolute indication extending two-thirds of circumference or more
ii) squamous cell carcinoma invading down to 1000 micro meter of submucosal layer

Key exclusion criteria

No indication of general anesthesia

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Takahiro
Middle name
Last name Hoshi

Organization

Institute of Community Medicine, Niigata University Medical and Dental Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

949-7302

Address

4132 Urasa, Minami Uonuma, Niigata

TEL

81-25-777-3200

Email

thoshi0725@yahoo.co.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Suda

Organization

Institute of Community Medicine, Niigata University Medical and Dental Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

949-7302

Address

4132 Urasa, Minami Uonuma, Niigata

TEL

81-25-777-3200

Homepage URL


Email

tspitt@med.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name



Funding Source

Organization

Niigata University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Institute of Community Medicine, Niigata University Hospital

Address

4132 Urasa, Minami Uonuma, Niigata

Tel

025-777-3200

Email

tspitt@med.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

魚沼基幹病院(新潟県)


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 07 Day

Date of IRB

2018 Year 08 Month 07 Day

Anticipated trial start date

2018 Year 09 Month 01 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry

2021 Year 08 Month 31 Day

Date trial data considered complete

2021 Year 08 Month 31 Day

Date analysis concluded

2022 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 08 Month 08 Day

Last modified on

2023 Year 08 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038392


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name